BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21346381)

  • 21. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials.
    Bex A; Jonasch E; Kirkali Z; Mejean A; Mulders P; Oudard S; Patard JJ; Powles T; van Poppel H; Wood CG
    Eur Urol; 2010 Dec; 58(6):819-28. PubMed ID: 20828919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of potential molecular markers in renal cell carcinoma: impact on clinicopathological outcomes in patients undergoing radical nephrectomy.
    Sakai I; Miyake H; Takenaka A; Fujisawa M
    BJU Int; 2009 Oct; 104(7):942-6. PubMed ID: 19388989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues.
    Capitanio U; Montorsi F
    Eur Urol; 2011 Jun; 59(6):929-30. PubMed ID: 21444146
    [No Abstract]   [Full Text] [Related]  

  • 24. A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
    Zini L; Perrotte P; Jeldres C; Capitanio U; Duclos A; Jolivet-Tremblay M; Arjane P; Péloquin F; Pharand D; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):899-904; discussion 904. PubMed ID: 19154499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
    Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of lymph node invasion and sarcomatoid differentiation on the survival of patients with locally advanced renal cell carcinoma.
    Rodríguez-Covarrubias F; Castillejos-Molina R; Sotomayor M; Méndez-Probst CE; Gómez-Alvarado MO; Uribe-Uribe N; Gabilondo F; Feria-Bernal G
    Urol Int; 2010; 85(1):23-9. PubMed ID: 20693824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma.
    Zini L; Perrotte P; Jeldres C; Capitanio U; Pharand D; Arjane P; Lapointe S; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2008 Dec; 102(11):1610-4. PubMed ID: 18710442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
    Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience.
    Ciancio G; Manoharan M; Katkoori D; De Los Santos R; Soloway MS
    Eur Urol; 2010 Apr; 57(4):667-72. PubMed ID: 19560258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
    Singh KJ; Singh SK; Suri A; Vijjan V; Goswami AK; Khullar M
    Indian J Cancer; 2005; 42(4):197-200. PubMed ID: 16391438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conditional survival predictions after nephrectomy for renal cell carcinoma.
    Karakiewicz PI; Suardi N; Capitanio U; Isbarn H; Jeldres C; Perrotte P; Sun M; Ficarra V; Zigeuner R; Tostain J; Mejean A; Cindolo L; Pantuck AJ; Belldegrun AS; Zini L; de la Taille A; Chautard D; Descotes JL; Shariat SF; Valeri A; Mulders PF; Lang H; Lechevallier E; Patard JJ
    J Urol; 2009 Dec; 182(6):2607-12. PubMed ID: 19836798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.
    Uygur MC; Usubütün A; Ozen H; Ayhan A; Kendi S
    J Exp Clin Cancer Res; 1999 Sep; 18(3):397-401. PubMed ID: 10606187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of treatment outcome and prognostic factors of renal cell cancer].
    Kanamaru H; Shirahase T; Isogawa Y; Moroi S; Kihara Y; Okuno H; Kuo JY; Taniguchi T; Arai Y; Tanaka Y
    Hinyokika Kiyo; 1994 Jan; 40(1):5-8. PubMed ID: 8109474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
    Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment outcome of 288 cases of renal cell carcinoma].
    Kitamura Y; Watanabe M; Komatsubara S; Sakata Y; Abe N; Mineyama H; Anezaki M; Chiba E
    Hinyokika Kiyo; 1996 Jan; 42(1):11-6. PubMed ID: 8686576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.